Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 17;10(3):463.
doi: 10.3390/vaccines10030463.

Susceptibility to Vaccine-Preventable Diseases in Four Districts of Xaysomboun Province, Lao People's Democratic Republic

Affiliations

Susceptibility to Vaccine-Preventable Diseases in Four Districts of Xaysomboun Province, Lao People's Democratic Republic

Siriphone Virachith et al. Vaccines (Basel). .

Abstract

Xaysomboun province has some of the lowest health indicators in Lao People's Democratic Republic (PDR). This cross-sectional study aimed to determine the vaccination, susceptibility and exposure status of the population to hepatitis B virus (HBV), measles, rubella, and tetanus. Participants aged 5 years and older were randomly selected from four districts. From each enrolled participant, demographic data and 5 mL of blood sample were taken. HBV surface antigen (HBsAg) and antibodies against HBV, measles, rubella, and tetanus were detected by ELISA. A total of 363 participants (age 5 to 80 years) were included. HBV exposure, as determined by anti-HBV core (anti-HBc) antibodies, was 56.2% overall, and was significantly higher among those aged ≥21 years (78.1%). HBsAg was detected in 9.4% overall and increased to 20% in ages 31-40 years. Only 13.8% of participants had serology indicative of vaccination (anti-HBs positive, anti-HBc negative). Seroprotection against measles was 74.6% overall but only 41.7% in children aged 5-10 years. Anti-rubella IgG was 94.2% overall and high in all age groups. Tetanus seroprevalence was only 47.4% overall but significantly higher in females aged 31-40 (75.6%). We suggest strengthening of routine and booster HBV, measles, and tetanus vaccine coverage in Xaysomboun province.

Keywords: Laos; antibodies; diphtheria; hepatitis B; measles; rubella; tetanus; vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Age-stratified Hepatitis B serology.
Figure 2
Figure 2
Age-stratified anti-measles and anti-rubella median antibody titers by age group. The horizontal dotted line represents the positivity cut-off for anti-measles (275 IU/L) and anti-rubella (11 IU/mL) antibodies.
Figure 3
Figure 3
Age-stratified tetanus seroprevalence status according to sex. (A) Male; (B) female.

Similar articles

Cited by

References

    1. Rodrigues C.M.C., Plotkin S.A. Impact of Vaccines; Health, Economic and Social Perspectives. Front. Microbiol. 2020;11:1526. doi: 10.3389/fmicb.2020.01526. - DOI - PMC - PubMed
    1. Cutts F.T., Hanson M. Seroepidemiology: An underused tool for designing and monitoring vaccination programmes in low- and middle-income countries. Trop. Med. Int. Health. 2016;21:1086–1098. doi: 10.1111/tmi.12737. - DOI - PubMed
    1. Funk S., Knapp J.K., Lebo E., Reef S.E., Dabbagh A.J., Kretsinger K., Jit M., Edmunds W.J., Strebel P.M. Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination. BMC Med. 2019;17:1–12. doi: 10.1186/s12916-019-1413-7. - DOI - PMC - PubMed
    1. Jutavijittum P., Andernach I.E., Yousukh A., Samountry B., Samountry K., Thammavong T., Keokhamphue J., Toriyama K., Muller C.P. Occult hepatitis B infections among blood donors in Lao PDR. Vox Sang. 2014;106:31–37. doi: 10.1111/vox.12073. - DOI - PubMed
    1. Black A.P., Nouanthong P., Nanthavong N., Souvannaso C., Vilivong K., Jutavijittum P., Samountry B., Lütteke N., Hübschen J.M., Goossens S., et al. Hepatitis B virus in the Lao People’s Democratic Republic: A cross sectional serosurvey in different cohorts. BMC Infect. Dis. 2014;14:1–7. doi: 10.1186/1471-2334-14-457. - DOI - PMC - PubMed

LinkOut - more resources